• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

IVQ Initial Director's Interest Notice - Kit Wei Lui14/03/19
IVQ Final Director's Interest Notice - Khoo Gee Choo (Jamie)14/03/19
IVQ Board changes11/03/19
IVQ Cleansing statement06/03/19
IVQ Appendix 3B06/03/19
IVQ Half Yearly Report and AccountsPRICE SENSITIVE28/02/19
IVQ IVQ appoints Professor Arial Zeng Yi as PDO consultant18/02/19
IVQ IVQ joint venture with A*STAR scientist Dr. Chen QingfengPRICE SENSITIVE11/02/19
IVQ Quarterly Appendix 4C and Business updatesPRICE SENSITIVE31/01/19
IVQ IVQ signs agreement to develop Onco-PDO breast cancer modelsPRICE SENSITIVE23/01/19
IVQ IVQ roll-out of Onco-PDO services in GermanyPRICE SENSITIVE18/01/19
IVQ IVQ appoints Prof Jesus Garcia-Foncillas as clinical advisor15/01/19
IVQ Expiry of unlisted options15/01/19
IVQ Appointment of Professor Masakazu Toi as Clinical Advisor11/01/19
IVQ Final Director's Interest Notice - Chow Yee Koh11/01/19
IVQ Board changes09/01/19
IVQ Change of Director's Interest Notice - Jamie Khoo (amend)24/12/18
IVQ Change of Director's Interest Notice - Andreas Lindner20/12/18
IVQ Change of Director's Interest Notice - Jamie Khoo19/12/18
IVQ Change of Director's Interest Notice - Ee Ting Ng18/12/18
IVQ Change of Director's Interest Notice - Hanry Yu18/12/18
IVQ Change of Director's Interest Notice - Chow Yee Koh18/12/18
IVQ Change of Director's Interest Notice - Boon Sing Fang18/12/18
IVQ Cleansing statement17/12/18
IVQ Appendix 3B17/12/18
IVQ Results of Meeting29/11/18
IVQ Change of Director's Interest Notice - Chow Yee23/11/18
IVQ Dr Lindner as Europe CEO and Prof Waugh as Senior Advisor19/11/18
IVQ Quarterly Appendix 4C and Business updatesPRICE SENSITIVE31/10/18
IVQ Notice of Annual General Meeting/Proxy Form29/10/18
IVQ Initial Director's Interest Notice - Dr Gary W Pace23/10/18
IVQ Appointment of Dr. Gary W. Pace as director23/10/18
IVQ Assoc Prof Iyer as Chair of IVQ Medical Advisory Board19/10/18
IVQ Appendix 4G28/09/18
IVQ Annual Report to shareholders28/09/18
IVQ Ceasing to be a substantial holder10/09/18
IVQ Business updates04/09/18
IVQ Preliminary Final ReportPRICE SENSITIVE31/08/18
IVQ Change in substantial holding28/08/18
IVQ Appendix 4C - quarterlyPRICE SENSITIVE31/07/18
IVQ Expiry of Unlisted Warrants17/07/18
IVQ Expiry of Unlisted Warrants02/07/18
IVQ Cleansing statement28/06/18
IVQ Appendix 3B28/06/18
IVQ Proposed issue of securities26/06/18
IVQ Change in substantial holding25/05/18
IVQ Appendix 4C - quarterlyPRICE SENSITIVE30/04/18
IVQ Appendix 4G27/04/18
IVQ IVQ launches Personalised Cancer Screening Service Onco-PDOPRICE SENSITIVE13/04/18
IVQ Half Yearly Report and AccountsPRICE SENSITIVE28/02/18
IVQ Grant from Northern Ireland to commercialize Onco-PDOPRICE SENSITIVE26/02/18
IVQ Investor presentation23/02/18
IVQ Change of Director's Interest Notice - Jamie Khoo20/02/18
IVQ Change of Director's Interest Notice - Steven Fang20/02/18
IVQ Change of Director's Interest Notice - Hanry Yu20/02/18
IVQ Change of Director's Interest Notice14/02/18
IVQ Change of Director's Interest Notice14/02/18
IVQ Change of Director's Interest Notice14/02/18
IVQ Change of Director's Interest Notice14/02/18
IVQ Change of Director's Interest Notice14/02/18
IVQ Initial Director's Interest Notice12/02/18
IVQ Appendix 3B09/02/18
IVQ Appointment of non-executive director07/02/18
IVQ Appendix 4C & quarterly business updatePRICE SENSITIVE31/01/18
IVQ Appendix 3B29/01/18
IVQ IVQ successfully grows liver cancer organoidsPRICE SENSITIVE18/01/18
IVQ Escrow release15/01/18
IVQ Cleansing statement08/12/17
IVQ Appendix 3B08/12/17
IVQ Proposed issue of securities07/12/17
IVQ Results of Meeting30/11/17
IVQ 2017 AGM Presentation30/11/17
IVQ Cleansing statement13/11/17
IVQ Appendix 3B13/11/17
IVQ Proposed issue of securitiesPRICE SENSITIVE10/11/17
IVQ Business updates31/10/17
IVQ Appendix 4C - quarterlyPRICE SENSITIVE30/10/17
IVQ Notice of Annual General Meeting/Proxy Form30/10/17
IVQ Annual Report to shareholders29/09/17
IVQ Appointments to management team28/09/17
IVQ Preliminary Final ReportPRICE SENSITIVE31/08/17
IVQ IVQ receives award from Singapore government IP officePRICE SENSITIVE29/08/17
IVQ Investor Presentation23/08/17
IVQ Appendix 4C quarterly and Business UpdatePRICE SENSITIVE31/07/17
IVQ Establishment of joint lab with Genome Institute SingaporePRICE SENSITIVE20/07/17
IVQ Updates to IVQ's collaboration with the Garvan InstitutePRICE SENSITIVE03/07/17
IVQ Cleansing Statement30/06/17
IVQ Appendix 3B30/06/17
IVQ Proposed issue of securitiesPRICE SENSITIVE29/06/17
IVQ Corporate Governance Statement24/05/17
IVQ IVQ expands into in-vitro skin and wound healing assaysPRICE SENSITIVE22/05/17
IVQ Response to ASX Appendix 4C QueryPRICE SENSITIVE11/05/17
IVQ Appendix 4C - quarterlyPRICE SENSITIVE28/04/17
IVQ Half Yearly Report and AccountsPRICE SENSITIVE28/02/17
IVQ Collaboration with the Garvan Institute of Medical ResearchPRICE SENSITIVE23/02/17
IVQ Appendix 4C - quarterlyPRICE SENSITIVE30/01/17
IVQ Escrow release03/01/17
IVQ Results of Meeting30/11/16
IVQ Dr. Ramanuj DasGupta to join as Senior Scientific Director24/11/16
IVQ Change of Address22/11/16
IVQ Initial Director's Interest Notice - Kit Wei Lui
14/03/19
IVQ Final Director's Interest Notice - Khoo Gee Choo (Jamie)
14/03/19
IVQ Board changes
11/03/19
IVQ Cleansing statement
06/03/19
IVQ Appendix 3B
06/03/19
IVQ Half Yearly Report and Accounts
28/02/19PRICE SENSITIVE
IVQ IVQ appoints Professor Arial Zeng Yi as PDO consultant
18/02/19
IVQ IVQ joint venture with A*STAR scientist Dr. Chen Qingfeng
11/02/19PRICE SENSITIVE
IVQ Quarterly Appendix 4C and Business updates
31/01/19PRICE SENSITIVE
IVQ IVQ signs agreement to develop Onco-PDO breast cancer models
23/01/19PRICE SENSITIVE
IVQ IVQ roll-out of Onco-PDO services in Germany
18/01/19PRICE SENSITIVE
IVQ IVQ appoints Prof Jesus Garcia-Foncillas as clinical advisor
15/01/19
IVQ Expiry of unlisted options
15/01/19
IVQ Appointment of Professor Masakazu Toi as Clinical Advisor
11/01/19
IVQ Final Director's Interest Notice - Chow Yee Koh
11/01/19
IVQ Board changes
09/01/19
IVQ Change of Director's Interest Notice - Jamie Khoo (amend)
24/12/18
IVQ Change of Director's Interest Notice - Andreas Lindner
20/12/18
IVQ Change of Director's Interest Notice - Jamie Khoo
19/12/18
IVQ Change of Director's Interest Notice - Ee Ting Ng
18/12/18
IVQ Change of Director's Interest Notice - Hanry Yu
18/12/18
IVQ Change of Director's Interest Notice - Chow Yee Koh
18/12/18
IVQ Change of Director's Interest Notice - Boon Sing Fang
18/12/18
IVQ Cleansing statement
17/12/18
IVQ Appendix 3B
17/12/18
IVQ Results of Meeting
29/11/18
IVQ Change of Director's Interest Notice - Chow Yee
23/11/18
IVQ Dr Lindner as Europe CEO and Prof Waugh as Senior Advisor
19/11/18
IVQ Quarterly Appendix 4C and Business updates
31/10/18PRICE SENSITIVE
IVQ Notice of Annual General Meeting/Proxy Form
29/10/18
IVQ Initial Director's Interest Notice - Dr Gary W Pace
23/10/18
IVQ Appointment of Dr. Gary W. Pace as director
23/10/18
IVQ Assoc Prof Iyer as Chair of IVQ Medical Advisory Board
19/10/18
IVQ Appendix 4G
28/09/18
IVQ Annual Report to shareholders
28/09/18
IVQ Ceasing to be a substantial holder
10/09/18
IVQ Business updates
04/09/18
IVQ Preliminary Final Report
31/08/18PRICE SENSITIVE
IVQ Change in substantial holding
28/08/18
IVQ Appendix 4C - quarterly
31/07/18PRICE SENSITIVE
IVQ Expiry of Unlisted Warrants
17/07/18
IVQ Expiry of Unlisted Warrants
02/07/18
IVQ Cleansing statement
28/06/18
IVQ Appendix 3B
28/06/18
IVQ Proposed issue of securities
26/06/18
IVQ Change in substantial holding
25/05/18
IVQ Appendix 4C - quarterly
30/04/18PRICE SENSITIVE
IVQ Appendix 4G
27/04/18
IVQ IVQ launches Personalised Cancer Screening Service Onco-PDO
13/04/18PRICE SENSITIVE
IVQ Half Yearly Report and Accounts
28/02/18PRICE SENSITIVE
IVQ Grant from Northern Ireland to commercialize Onco-PDO
26/02/18PRICE SENSITIVE
IVQ Investor presentation
23/02/18
IVQ Change of Director's Interest Notice - Jamie Khoo
20/02/18
IVQ Change of Director's Interest Notice - Steven Fang
20/02/18
IVQ Change of Director's Interest Notice - Hanry Yu
20/02/18
IVQ Change of Director's Interest Notice
14/02/18
IVQ Change of Director's Interest Notice
14/02/18
IVQ Change of Director's Interest Notice
14/02/18
IVQ Change of Director's Interest Notice
14/02/18
IVQ Change of Director's Interest Notice
14/02/18
IVQ Initial Director's Interest Notice
12/02/18
IVQ Appendix 3B
09/02/18
IVQ Appointment of non-executive director
07/02/18
IVQ Appendix 4C & quarterly business update
31/01/18PRICE SENSITIVE
IVQ Appendix 3B
29/01/18
IVQ IVQ successfully grows liver cancer organoids
18/01/18PRICE SENSITIVE
IVQ Escrow release
15/01/18
IVQ Cleansing statement
08/12/17
IVQ Appendix 3B
08/12/17
IVQ Proposed issue of securities
07/12/17
IVQ Results of Meeting
30/11/17
IVQ 2017 AGM Presentation
30/11/17
IVQ Cleansing statement
13/11/17
IVQ Appendix 3B
13/11/17
IVQ Proposed issue of securities
10/11/17PRICE SENSITIVE
IVQ Business updates
31/10/17
IVQ Appendix 4C - quarterly
30/10/17PRICE SENSITIVE
IVQ Notice of Annual General Meeting/Proxy Form
30/10/17
IVQ Annual Report to shareholders
29/09/17
IVQ Appointments to management team
28/09/17
IVQ Preliminary Final Report
31/08/17PRICE SENSITIVE
IVQ IVQ receives award from Singapore government IP office
29/08/17PRICE SENSITIVE
IVQ Investor Presentation
23/08/17
IVQ Appendix 4C quarterly and Business Update
31/07/17PRICE SENSITIVE
IVQ Establishment of joint lab with Genome Institute Singapore
20/07/17PRICE SENSITIVE
IVQ Updates to IVQ's collaboration with the Garvan Institute
03/07/17PRICE SENSITIVE
IVQ Cleansing Statement
30/06/17
IVQ Appendix 3B
30/06/17
IVQ Proposed issue of securities
29/06/17PRICE SENSITIVE
IVQ Corporate Governance Statement
24/05/17
IVQ IVQ expands into in-vitro skin and wound healing assays
22/05/17PRICE SENSITIVE
IVQ Response to ASX Appendix 4C Query
11/05/17PRICE SENSITIVE
IVQ Appendix 4C - quarterly
28/04/17PRICE SENSITIVE
IVQ Half Yearly Report and Accounts
28/02/17PRICE SENSITIVE
IVQ Collaboration with the Garvan Institute of Medical Research
23/02/17PRICE SENSITIVE
IVQ Appendix 4C - quarterly
30/01/17PRICE SENSITIVE
IVQ Escrow release
03/01/17
IVQ Results of Meeting
30/11/16
IVQ Dr. Ramanuj DasGupta to join as Senior Scientific Director
24/11/16
IVQ Change of Address
22/11/16
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.